News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
New and experimental hepatitis C treatment
Vertex study will evaluate 12-week treatment period for some hepatitis C patients

Five months after it received regulatory approval for a potential blockbuster hepatitis C drug called Incivek, Vertex Pharmaceuticals Inc. said it is launching a study to evaluate whether some patients can benefit from 12 weeks of treatment rather than 24 or 48 weeks.

Published
24 October 2011
From
Boston.com
Hepatitis C treatment
Hepatitis C drug boceprevir achieves 70% viral suppression rate in HIV co-infected people within 24 weeks

Interim results presented at the Infectious Diseases Society of America (IDSA) conference yesterday show that 70.5% of 98 patients with HIV and hepatitis C who took the

Published
22 October 2011
By
Gus Cairns
New and experimental hepatitis C treatment
Abbott says hepatitis C combo may be a blockbuster

Abbott Laboratories Inc said on Friday that it could have a shorter duration combination therapy for hepatitis C on the market in 2015 with annual sales potential of about $2 billion.

Published
21 October 2011
From
Reuters
Hepatitis C symptoms and diagnosis
India: Integrate Hepatitis C testing with HIV: NGOs

New Delhi, Oct 21 (IANS) With over 13 million cases of hepatitis C virus (HCV) in India, NGOs Friday urged the National AIDS Control Organisation (NACO) to include testing and treatment guidelines for the disease in its intervention targeted at HIV.

Published
21 October 2011
From
Yahoo News
Hepatitis B
'PATH B', a comprehensive support program in Europe for patients with chronic hepatitis B launched

A pioneering educational resource, designed to improve the lives of people living with chronic hepatitis B, was launched today at an annual conference organised by Bristol-Myers Squibb in Hong Kong where 26 patient advocacy groups from 14 countries and regions gathered to discuss viral hepatitis.

Published
21 October 2011
From
Eurekalert Medicine & Health
New and experimental hepatitis C treatment
Interim Phase IIb Data for Merck's VICTRELIS™ (boceprevir) in Patients Coinfected with Chronic Hepatitis C and HIV-1

The interim analysis showed that at week 24 of treatment, 70.5 percent (n=43/61) of patients receiving VICTRELIS in combination with peginterferon alfa-2b and ribavirin had undetectable hepatitis C virus (HCV-RNA) compared to 34.4 percent (n=11/32) of patients receiving peginterferon alfa-2b and ribavirin alone, a treatment difference of 36.1 percent.

Published
20 October 2011
From
Market Watch (press release)
Hepatitis C treatment
EACS: Antiretroviral Therapy Reduces Liver Fibrosis Progression in HIV/HCV Coinfected People

Earlier initiation of antiretroviral therapy (ART) and spending more time on HIV treatment may help slow liver disease progression in HIV/HCV co-infected patients, according to an Italian study using non-invasive methods presented at the 13th European AIDS Conference (EACS 2011) last week in Belgrade.

Published
20 October 2011
From
HIVandhepatitis.com
New and experimental hepatitis C treatment
Sector Snap: Hepatitis C drug developers rise

Shares of companies who are studying potential new treatments for hepatitis C rose Monday after Swiss drugmaker Roche agreed to buy Anadys Pharmaceuticals Inc. for $230 million.

Published
18 October 2011
From
Bloomberg Business Week
Treatment guidelines
New European HIV treatment guidelines expand treatment recommendations but anticipate possible drug shortages

The new edition of the European AIDS Clinical Society (EACS) treatment guidelines for people with HIV was published last week at the 13th European AIDS Conference in Belgrade,

Published
18 October 2011
By
Gus Cairns
Injecting drug use
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

Together studies recently conducted across the UK suggest that consistent participation in methadone maintenance treatment plus adequate access to fresh injecting equipment has prevented many hepatitis C infections, supporting calls for needle exchange to be expanded and methadone treatment sustained.

Published
18 October 2011
From
Drug and Alcohol Findings
← Prev1...4950515253...103Next →

Filter by country